Literature DB >> 9004540

Enhanced secretory ability for the human factor VIII light chain produced in baculovirus-infected insect cells.

E Webb1, J Tkalcevic, S Edwards, D Hocking, I Nisbet.   

Abstract

The light and truncated heavy chains of human factor VIII, expressed separately in baculovirus-infected insect cells, exhibited different secretory behaviour when compared with each other and with a biologically active fusion molecule of the truncated heavy and light chains. The light chain was very efficiently secreted into culture medium, as judged by high extracellular protein levels and the absence of evidence for light chain retention within cells. Alternatively, proteins containing the heavy chain sequence were poorly secreted and appeared to be sequestered within cells, suggesting that regions within the heavy chain are responsible for the low levels of secreted protein which have generally been observed for recombinant factor VIII.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004540     DOI: 10.1007/bf02215666

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  9 in total

1.  Peptide-binding specificity of the molecular chaperone BiP.

Authors:  G C Flynn; J Pohl; M T Flocco; J E Rothman
Journal:  Nature       Date:  1991-10-24       Impact factor: 49.962

2.  Genetic engineering of factor VIII.

Authors:  R J Kaufman
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

Review 3.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.

Authors:  W H Kane; E W Davie
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

4.  A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.

Authors:  J J Toole; D D Pittman; E C Orr; P Murtha; L C Wasley; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Expression of active human factor VIII from recombinant DNA clones.

Authors:  W I Wood; D J Capon; C C Simonsen; D L Eaton; J Gitschier; B Keyt; P H Seeburg; D H Smith; P Hollingshead; K L Wion; E Delwart; E G Tuddenham; G A Vehar; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

Review 6.  Folding and assembly of viral membrane proteins.

Authors:  R W Doms; R A Lamb; J K Rose; A Helenius
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

7.  Expression of biologically active human factor VIII using a baculovirus vector.

Authors:  E Webb; J Tkalcevic; S Edwards; D Hocking; I Nisbet
Journal:  Biochem Biophys Res Commun       Date:  1993-01-29       Impact factor: 3.575

8.  Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments.

Authors:  A Leyte; K Mertens; B Distel; R F Evers; M J De Keyzer-Nellen; M M Groenen-Van Dooren; J De Bruin; H Pannekoek; J A Van Mourik; M P Verbeet
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

9.  The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins.

Authors:  A J Dorner; D G Bole; R J Kaufman
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.